1-9 of 9
Charles G. Mullighan
Close
Sort by
Journal Articles

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL

Yaqi Zhao, A. Douglas Laird, Kathryn G. Roberts, Rolla Yafawi, Hagop Kantarjian, Daniel J. DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O’Brien, Elias Jabbour, Ryan D. Cassaday, Melanie R. Loyd, Scott Olsen, Geoffrey Neale, Xueli Liu, Erik Vandendries, Anjali Advani, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3226–3236.
https://doi.org/10.1182/bloodadvances.2023012430
Published: 2024
Includes: Supplemental data
Journal Articles

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia

Daniel C. Ferguson, J. Robert McCorkle, Kelly R. Barnett, Erik J. Bonten, Brennan P. Bergeron, Kashi Raj Bhattarai, Wenjian Yang, Colton Smith, Baranda S. Hansen, Richa Bajpai, Qian Dong, Robert J. Autry, Yoshihiro Gocho, Jonathan D. Diedrich, Kristine R. Crews, Shondra M. Pruett-Miller, Kathryn G. Roberts, Wendy Stock, Charles G. Mullighan, Hiroto Inaba, Sima Jeha, Ching-Hon Pui, Jun J. Yang, Mary V. Relling, William E. Evans, Daniel Savic
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3386–3397.
https://doi.org/10.1182/bloodadvances.2022006965
Published: 2022
Includes: Supplemental data
Journal Articles

G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL

Ilaria Iacobucci, Reiji Fukano, Jake D. Friske, Chunxu Qu, Laura J. Janke, Yaqi Zhao, Pradyuamna Baviskar, Emily A. Backhaus, Peter Chockley, Aman Seth, A. Douglas Laird, Anjali S. Advani, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3255–3259.
https://doi.org/10.1182/bloodadvances.2021004854
Published: 2022
Includes: Supplemental data
Journal Articles

VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group

Stuart S. Winter, Amanda McCaustland, Chunxu Qu, No’eau Simeona, Nyla A. Heerema, Andrew J. Carroll, Brent L. Wood, Gabriela Gheorghe, Charles G. Mullighan, Bridget S. Wilson
Journal: Blood Advances
Blood Adv (2022) 6 (2): 585–589.
https://doi.org/10.1182/bloodadvances.2021005245
Published: 2022
Includes: Supplemental data
Journal Articles

Cotargeting BCL-2 and MCL-1 in high-risk B-ALL

Donia M. Moujalled, Diane T. Hanna, Soroor Hediyeh-zadeh, Giovanna Pomilio, Lauren Brown, Veronique Litalien, Ray Bartolo, Shaun Fleming, Maïa Chanrion, Sébastien Banquet, Ana-Leticia Maragno, Laurence Kraus-Berthier, Marie Schoumacher, Charles G. Mullighan, Angela Georgiou, Christine A. White, Guillaume Lessene, David C. S. Huang, Andrew W. Roberts, Olivier Geneste, Lorna Rasmussen, Melissa J. Davis, Paul G. Ekert, Andrew Wei, Ashley P. Ng, Seong L. Khaw
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2762–2767.
https://doi.org/10.1182/bloodadvances.2019001416
Published: 2020
Includes: Supplemental data
Journal Articles

Germline deletion of ETV6 in familial acute lymphoblastic leukemia

Evadnie Rampersaud, David S. Ziegler, Ilaria Iacobucci, Debbie Payne-Turner, Michelle L. Churchman, Kasmintan A. Schrader, Vijai Joseph, Kenneth Offit, Katherine Tucker, Rosemary Sutton, Meera Warby, Georgia Chenevix-Trench, David G. Huntsman, Maria Tsoli, R. Scott Mead, Chunxu Qu, Vasiliki Leventaki, Gang Wu, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1039–1046.
https://doi.org/10.1182/bloodadvances.2018030635
Published: 2019
Journal Articles

The ASH Agenda for Hematology Research: a roadmap for advancing scientific discovery and cures for hematologic diseases

Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2430–2432.
https://doi.org/10.1182/bloodadvances.2018025403
Published: 2018
Journal Articles

Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice

Tomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, Sanjay S. Patel, Kathryn Roberts, Yue Kang, Ahmad Alduaij, Peter S. Dennis, Brian Lawney, Ruiyang Liu, Zeyuan Song, Jessie Xiong, Yunyu Zhang, Madeleine E. Lemieux, Geraldine S. Pinkus, Jeremy N. Rich, David M. Weinstock, Charles G. Mullighan, Norman E. Sharpless, Ruben D. Carrasco
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2361–2374.
https://doi.org/10.1182/bloodadvances.2017012211
Published: 2017
Includes: Supplemental data
Journal Articles

Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL

Kathryn G. Roberts, Yung-Li Yang, Debbie Payne-Turner, Wenwei Lin, Jacob K. Files, Kirsten Dickerson, Zhaohui Gu, Jack Taunton, Laura J. Janke, Taosheng Chen, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1657–1671.
https://doi.org/10.1182/bloodadvances.2017011296
Published: 2017
Includes: Supplemental data